MLXIPL and diabetes mellitus: Since the expression of ChREBP, especially the ChREBP-β isoform, is often downregulated in conditions predisposing to diabetes, therefore, restoration of ChREBP expression or activity in WATs might be an important therapeutic strategy to treat T2D and its complications.